Skip to content
Sign in
CVE-2022-473767.3HighCWE-257

CVE-2022-47376: Bd Alaris Infusion Central vulnerability

Bd · Alaris Infusion Central

Affected: Bd Alaris Infusion Central · Exploitation: unlikely (under 1%)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

0.2%probability of exploitation in the next 30 days
5th percentile
050100

Higher than 5% of scored CVEs

7.3HighCVSS 3.1
LowHigh

DescriptionCVE.org

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Affected products1

From the CVE record. A product or version that is not listed is unknown, not unaffected.

  • Alaris Infusion Central<=1.3.2

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas
Exploitation
Unlikely (under 1%). EPSS under 1%, or no score yet.
CISA KEV
Not listed
Public check
No public nuclei template
Vendor
Bd
Published
June 2023

CoverageNo articles yet

No CyberSIXT article names CVE-2022-47376 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.

References

Updated AboutDevelopersSign in